RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
This allows the full dose to deposit in the tissue and prevents medication from leaking back through the needle track when you withdraw
[20] Treatment of megaloblastic anemia with concurrent vitamin B 12 deficiency using B 12 vitamers (including cyanocobalamin), creates the possibility of hypokalemia due to increased erythropoiesis (red blood cell production) and consequent cellular uptake of potassium upon anemia resolution
[2] Age and overall health status also play important roles
Red Blood Cell Production : Vitamin B12 helps prevent anemia by supporting red blood cell formation, ensuring adequate oxygen delivery to tissues
FBNs platform helps you efficiently buy inputs and supplies more directly from manufacturers, access a marketplace of financing and premium marketing programs, connect to grain buyers, and unlock exclusive insights from over 100,000 member farms in the FBN network
